- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
PET/CT database helps daily clinical practice
Researchers at the Dana-Farber Cancer Institute in Boston have developed a PET/CT database of clinical data that are not usually available through conventional PACS and HIS/RIS.
Researchers at the Dana-Farber Cancer Institute in Boston have developed a PET/CT database of clinical data that are not usually available through conventional PACS and HIS/RIS.
Jeffery Yap, Ph.D., and colleagues at the institute's nuclear medicine/PET department use the database to query previous patient studies. The database contains more than 100 parameters organized in a variety of tables to optimize data entry and retrieval. It provides PET acquisition time, FDG dose, uptake time, CT technique, and plasma glucose level, among other figures. The investigators presented their findings in a poster at the 2007 SNM meeting (J Nucl Med 2007;48[Suppl 2]:199P).
"We use this information to ensure each patient's scan is performed consistently for repeat visits," Yap said.
Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer
January 3rd 2025Adjunctive AI offered greater than seven percent increases in sensitivity, specificity, and accuracy for ultrasound detection of ovarian cancer in comparison to unassisted clinicians who lacked ultrasound expertise, according to findings from new international multicenter research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
